A major acquisition deal has taken place by HEXO Corp. HEXO steps up with C$925 deal to buy privately-owned Canadian cannabis producer, Redecan. This comes after a deal In February, where HEXO said it was taking over Zenabis Global Inc for C$235 million, giving it access to the European medical cannabis market.
(Reuters) -HEXO Corp said on Friday it would buy Redecan, a privately-owned Canadian cannabis producer, for C$925 million ($764.72 million) in cash and stock, as the pot producer bolsters its portfolio to tap surging demand and position itself as a top recreational weed supplier.
Hexo shares rose 8% in morning trading.
Cannabis demand surged last year as many people turned to pot during COVID-19 lockdowns for entertainment and relaxation. The industry is now benefiting from hopes of federal marijuana reform in the United States following a recent wave of legalization that has swept many key U.S. states.
|Symbol||Name||Last Price||Change||% Change|
Legalization hopes have been driving a surge in dealmaking, with HEXO alone signing two other deals in the last five months. In February, HEXO said it was taking over Zenabis Global Inc for C$235 million, giving it access to the European medical cannabis market.
Earlier this month, HEXO announced the purchase of 48North Cannabis Corp for about C$50 million.
Company executives from both HEXO and Redecan noted the importance of a combined portfolio on a call with analysts, saying a “strong home market foundation is imperative to form meaningful international expansion.”
Mergers and acquisitions will be part of HEXO’s strategy until the company is one of the top three global cannabis products maker, HEXO’s Chief Executive Sebastien St-Louis said.
Redecan shareholders will get C$400 million in cash and C$525 million in HEXO shares at an implied price of C$7.53 at the close of the deal, which is expected in the third quarter of 2021.
Redecan shareholders will hold about 31% of the combined entity and will receive the right to nominate up to two members to HEXO’s board.
($1 = 1.2096 Canadian dollars)
HEXO steps up with C$925 deal
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.